Phase 3Completed
A Prospective, Multi-center Study to Evaluate the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in Adults With Vitamin D Deficiency
A Prospective, Multi-centre, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in Adults With Vitamin D Deficiency
- Sponsor
- Kwang Dong Pharmaceutical co., ltd. (Industry)
- Enrolment
- 84 enrolled
- Conditions
- Vitamin D Deficiency
- Interventions
- Vitamin D3 B.O.N. Injection (cholecalciferol 200,000IU); Placebo
- Ages
- adults, older adults
- Registry
- NCT02443246
Full record on ClinicalTrials.gov
From the registry
To compare the efficacy of Vitamin D3 B.O.N. Intramuscular Injection within 12 weeks with that of placebo in adults with Vitamin D Deficiency.
Primary outcomes
- Primary Efficacy Endpoints (serum 25(OH)D concentration)
History
Last registry update
Study completion
Primary completion
Registered
Started